Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS)

This study has been terminated.
(Recruitment difficult and enrolment low: decision was made to stop the study.)
Sponsor:
Collaborator:
McGill University
Information provided by:
McGill University Health Center
ClinicalTrials.gov Identifier:
NCT00689585
First received: May 29, 2008
Last updated: May 11, 2011
Last verified: May 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2010
  Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)